Immunoproteasome is up-regulated in rotenone-induced Parkinson’s disease rat model
Authors:
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 738, 135360
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shandong Province (2014WSB20030, BS2015YY041)
- National Natural Science Foundation of China (81471292, 81501100)
This publication has 38 references indexed in Scilit:
- Reactive glia show increased immunoproteasome activity in Alzheimer’s diseaseBrain, 2013
- Immuno- and Constitutive Proteasomes Do Not Differ in Their Abilities to Degrade Ubiquitinated ProteinsCell, 2013
- Immuno- and Constitutive Proteasome Crystal Structures Reveal Differences in Substrate and Inhibitor SpecificityCell, 2012
- Amyloid Generation and Dysfunctional Immunoproteasome Activation with Disease Progression in Animal Model of Familial Alzheimer's DiseaseBrain Pathology, 2011
- Towards a systems understanding of MHC class I and MHC class II antigen presentationNature Reviews Immunology, 2011
- A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsyBrain Research, 2010
- Whole genome survey of coding SNPs reveals a reproducible pathway determinant of Parkinson diseaseHuman Mutation, 2008
- Ubiquitin–proteasome system dysfunction in Parkinson’s disease: current evidence and controversiesExpert Review of Proteomics, 2007
- LMP2 Knock-Out Mice Have Reduced Proteasome Activities and Increased Levels of Oxidatively Damaged ProteinsAntioxidants & Redox Signaling, 2006
- Enhaced induction of the immunoproteasome by interferon gamma in neurons expressing mutant huntingtinNeurotoxicity Research, 2004